Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chlorosuccinimide | HCID 31398 | — |
| Reactant | HCID 9838573 | HCID 9838573 | — |
| Catalyst | Benzoyl Peroxide | HCID 7187 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 18612494 | HCID 18612494 | 74.1% |
Reaction Steps
6,11-Dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo[2,1-b][3]benzazepine (28 g) was stirred in DCM (500 ml), until complete dissolution. Dibenzoyl peroxide (0.1 g) was added. N-chlorosuccinimide (13.4 g) was added portionwise and the resulting reaction mixture was stirred overnight at room temperature, then for 2 hours at reflux temperature. The solvent was evaporated. The residue was purified by column chromatography over silica gel (eluent: CH2Cl2/(CH3OH/NH3) 97/3, upgrading to 95/5). The pure fractions were collected and the solvent was evaporated. The residue was crystallized from ACN. The precipitate was filtered off and dried, yielding 23.3 g (74%) of 3-chloro-6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo-[2,1-b][3]benzazepine (intemediate 11).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06544979B1 |
|---|
| Source dataset | uspto-grants-2003_04 |
|---|
| ORD ID | ord-91aac832141344f6bd7ec3348abf67a3 |
|---|
| Source note | uspto-grants-2003_04 |
|---|